AU1276899A - Type ix collagen antibody and related uses - Google Patents
Type ix collagen antibody and related usesInfo
- Publication number
- AU1276899A AU1276899A AU12768/99A AU1276899A AU1276899A AU 1276899 A AU1276899 A AU 1276899A AU 12768/99 A AU12768/99 A AU 12768/99A AU 1276899 A AU1276899 A AU 1276899A AU 1276899 A AU1276899 A AU 1276899A
- Authority
- AU
- Australia
- Prior art keywords
- type
- collagen antibody
- related uses
- collagen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6300697P | 1997-10-23 | 1997-10-23 | |
US60063006 | 1997-10-23 | ||
PCT/US1998/022616 WO1999021011A1 (en) | 1997-10-23 | 1998-10-23 | Type ix collagen antibody and related uses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1276899A true AU1276899A (en) | 1999-05-10 |
Family
ID=22046271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU12768/99A Abandoned AU1276899A (en) | 1997-10-23 | 1998-10-23 | Type ix collagen antibody and related uses |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1276899A (en) |
WO (1) | WO1999021011A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60142372D1 (en) | 2000-04-20 | 2010-07-22 | St Vincents Hosp Sydney | Diagnostic Assay with Macrophage Inhibiting Cytokine-1 (MIC-1) |
US7892768B2 (en) | 2007-03-02 | 2011-02-22 | Anamar Medical Ab | Diagnosis of collagen IX destruction |
EP2350669B9 (en) | 2008-10-31 | 2014-06-11 | St Vincent's Hospital Sydney Limited | Methods of prognosis in chronic kidney disease |
EP2295977A1 (en) * | 2009-09-03 | 2011-03-16 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008195A1 (en) * | 1989-01-13 | 1990-07-26 | President And Fellows Of Harvard College | Monoclonal antibody to human type ix collagen |
-
1998
- 1998-10-23 AU AU12768/99A patent/AU1276899A/en not_active Abandoned
- 1998-10-23 WO PCT/US1998/022616 patent/WO1999021011A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999021011A1 (en) | 1999-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6241698A (en) | Tace-like and matrilysin-like polypeptides | |
AU694696B2 (en) | Sulfonamides and their use | |
AU9790198A (en) | Compounds and methods | |
AU9781998A (en) | Huchordin and uses thereof | |
AU3702397A (en) | Anti-herpesviral agents and assays therefor | |
AU5091199A (en) | Prion protein and uses thereof | |
AU5340399A (en) | Proteases and associated proteins | |
GB9705903D0 (en) | VP22 Proteins and uses thereof | |
AU6222896A (en) | Collagen peptide fraction and its uses | |
AU2396600A (en) | Secreted proteins and uses thereof | |
IL124437A0 (en) | Type IX collagen and chimeras | |
AU7584696A (en) | Type ix collagen and fragments thereof | |
AU8695298A (en) | Compounds and uses thereof | |
AU3656497A (en) | Traf2-associated protein kinase and assays | |
AU1276899A (en) | Type ix collagen antibody and related uses | |
AU6000698A (en) | Proteins | |
AU2136401A (en) | P450rai-2 and related proteins | |
AU6160598A (en) | Differentiation enhancing factors and uses therefor | |
AU6962598A (en) | Thioredoxin-like protein | |
AU3411999A (en) | Novel rnase-like protein and its use | |
AU1664299A (en) | Autodegradable microcarriers and their use | |
AU7678898A (en) | New carbohydrates and use thereof | |
AU8693198A (en) | Compounds and uses thereof | |
AU1906599A (en) | Pancreatic-derived factors, and uses related thereto | |
AU1177700A (en) | Novel protein and utilization thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |